Translating molecular determinants of susceptibility and progression in breast cancer

转化乳腺癌易感性和进展的分子决定因素

• 批准号: nhmrc : 1113867
• 负责人: Prof Georgia Chenevix-Trench
• 金额: $ 445.1万
• 依托单位: Queensland Institute of Medical Research
• 依托单位国家: 澳大利亚
• 项目类别: Program Grants
• 财政年份: 2017
• 资助国家: 澳大利亚
• 起止时间: 2017-01-01 至 2021-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/translating-molecular-determinants-breast-cancer/663286
• 关键词: Translating; molecular; determinants; susceptibility; progression

Breast cancer is the most common cancer in women. Despite improvements in prevention, detection and treatment, it is the 2nd most common cause of cancer death in Australian women. Research advances in the last decade have improved our understanding of the pathways from susceptibility to progression and metastasis but this has mostly not yet translated into better outcomes. This program aims to translate some of our fundamental discoveries to improve outcome for affected women and their families.

乳腺癌是女性最常见的癌症。尽管在预防、检测和治疗方面有所改进，但它仍是澳大利亚妇女癌症死亡的第二大常见原因。过去十年的研究进展提高了我们对从易感性到进展和转移的途径的理解，但这大多尚未转化为更好的结果。该计划旨在将我们的一些基本发现转化为改善受影响妇女及其家庭的结果。